InsidersTradesSigma
Explore the full record of transactions filed by Ciulla Thomas, Directeur Médical. Officer active across 1 companies, notably Clearside Biomedical, Inc.. Cumulatively, 6 reports have been recorded. Total volume traded: €28k. The latest transaction was disclosed on 18 January 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
6 of 6 declarations
Thomas Ciulla is the Chief Medical Officer at Clearside Biomedical, Inc. He is responsible for the medical direction and product development strategy. Thomas leverages his expertise to guide clinical initiatives and ensure the safety and efficacy of the treatments offered by the company.